Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
Journal article published in 1999 by
E. Negredo,
R. Paredes 
,
A. Bonjoch,
A. Tuldra,
C. R. Fumaz,
S. Gel,
B. Garces,
S. Johnston,
A. Arno,
M. Balague
,
A. Bonjoch,
A. Tuldra,
C. R. Fumaz,
S. Gel,
B. Garces,
S. Johnston,
A. Arno,
M. Balague
